Trial Profile
A Retrospective, Observational study to evaluate the treatment persistence of basal insulin (insulin glargine or insulin detemir) and its impact on A1c levels in patients with Type II Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 20 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association